Step 1 topics → Immunology → B Cell Deficiencies

B Cell Deficiencies

USMLE Step 1 trap: Expects XLA to present at birth, not recognizing the protective role of maternal IgG in the first 6 months. XLA presents after 6 months of age when maternal IgG wanes, revealing the infant's inability to produce its own immunoglobulins.

B cell deficiencies are a high-yield immunology topic that shows up repeatedly on USMLE Step 1, and the exam is specifically designed to trip you up on the clinical details that distinguish one condition from another. These disorders all result in impaired humoral immunity — meaning reduced or absent immunoglobulins — but they differ in mechanism, age of onset, inheritance, lab findings, and associated risks. The four you need cold are XLA (Bruton), Selective IgA deficiency, CVID, and Hyper-IgM syndrome. If you treat them as a single category of 'low antibody diseases,' you will miss questions.

The exam tests this topic from multiple angles. Pure recall questions ask you to match a lab pattern or gene defect to a diagnosis. Application questions give you a clinical vignette — a male infant with recurrent bacterial infections, an adult with recurrent pneumonias and newly diagnosed lymphoma, a patient who had an anaphylactic reaction to a blood transfusion — and ask you to identify the diagnosis or explain the mechanism. The trickiest questions embed the clinical scenario in a longer passage and expect you to recognize what's abnormal (e.g., normal B cell count with absent plasma cell differentiation in CVID) versus what's absent entirely (no B cells at all in XLA).

The most common failure modes here are not knowing when XLA actually presents (hint: not at birth), conflating CVID with XLA because both cause low immunoglobulins, missing the transfusion anaphylaxis risk in IgA deficiency, and misattributing Hyper-IgM to a B cell problem when it's actually a T helper cell signaling defect. USMLE Step 1 loves all four of these misconceptions. Fix your mental model on each one and you'll convert these into reliable points.

From real student decks
76%have cards covering this topic
51%have mature cards

Common misconceptions

Common mistake
Wrong: XLA (Bruton) presents at birth because it is congenital.
Right: XLA presents after 6 months of age when maternal IgG wanes, revealing the infant's inability to produce its own immunoglobulins.
XLA is congenital in the sense that the BTK mutation is present from birth, but the infant doesn't present clinically at birth because maternal IgG crosses the placenta and provides passive protection for the first 4–6 months of life. Once maternal antibodies wane around 6 months, the infant's inability to produce its own immunoglobulins is exposed and recurrent bacterial infections begin. If a question stem describes a newborn or a 1-month-old with immunodeficiency, XLA is not the right answer — look for a different diagnosis.
Common mistake
Wrong: Selective IgA deficiency is dangerous primarily because of recurrent sinopulmonary infections.
Right: While recurrent sinopulmonary infections occur, the most high-yield danger is anaphylaxis upon transfusion of blood products containing IgA, because patients have anti-IgA antibodies.
Yes, Selective IgA deficiency causes recurrent sinopulmonary and GI infections, and that's worth knowing. But the reason this condition gets its own high-yield question is the transfusion risk: patients with IgA deficiency develop anti-IgA IgG antibodies, and when they receive blood products containing IgA (which includes standard packed RBCs, FFP, and platelets), they can have a severe anaphylactic reaction. This is why IgA-deficient patients must receive IgA-depleted or washed blood products. The exam will almost always make the transfusion scenario the punchline of the question.
Common mistake
Wrong: Hyper-IgM syndrome is caused by B cell intrinsic failure to produce IgG.
Right: Hyper-IgM is most commonly caused by a defect in CD40L on T helper cells (or CD40 on B cells), preventing the T-B interaction required for class-switch recombination from IgM to IgG/IgA/IgE.
Hyper-IgM syndrome looks like a B cell problem on the surface — low IgG, low IgA, low IgE — but the B cells themselves are capable of making IgM just fine. The defect is upstream: T helper cells lack functional CD40L, so when they engage B cells via CD40-CD40L interaction (the signal required for germinal center class-switch recombination), nothing happens. B cells stay stuck making IgM. Because this also disrupts T-B cooperation more broadly, patients get opportunistic infections like PCP and Cryptosporidium that you wouldn't expect from a pure antibody deficiency — that's your clue on the exam that something beyond just B cells is wrong.
Common mistake
Wrong: CVID and XLA are clinically identical because both cause pan-hypogammaglobulinemia.
Right: CVID presents in adults (20s–30s) of either sex with normal B cell numbers but poor differentiation into plasma cells, and carries increased risk of autoimmune disease and lymphoma, unlike XLA which presents in male infants with absent B cells.
Both XLA and CVID cause pan-hypogammaglobulinemia, which is where students merge them. The key differentiators are: XLA hits male infants (X-linked, BTK mutation, absent B cells on flow cytometry); CVID hits adults in their 20s–30s of either sex, with normal or near-normal B cell numbers but those B cells can't differentiate into antibody-secreting plasma cells. CVID also carries a significantly increased risk of autoimmune disease and B cell lymphoma — risks that don't characterize XLA. When the vignette gives you an adult woman with low immunoglobulins and a new lymphoma diagnosis, that's CVID, not XLA.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Given a clinical vignette of a male infant with recurrent bacterial sinopulmonary infections starting around 6–9 months of age, absent B cells, and very low immunoglobulins across all classes, identify this as XLA (Bruton agammaglobulinemia), explain the BTK mutation, and recognize the X-linked recessive inheritance pattern.
  2. Identify Selective IgA deficiency as the most common primary immunodeficiency, recognize that affected patients have recurrent sinopulmonary and GI infections but selectively low IgA with normal IgG and IgM, and — critically — know that the highest-yield danger on the exam is anaphylaxis to IgA-containing blood products due to pre-formed anti-IgA antibodies.
  3. Distinguish CVID from XLA by age of onset (adults in their 20s–30s vs. male infants), B cell count (normal numbers but impaired differentiation vs. absent B cells), and the unique associated risks of CVID: autoimmune disease, lymphoma (especially non-Hodgkin), and granuloma formation.
  4. Explain the mechanism of Hyper-IgM syndrome as a failure of class-switch recombination due to a defect in CD40L on T helper cells (or, less commonly, CD40 on B cells), resulting in elevated IgM with absent IgG/IgA/IgE, and recognize the associated susceptibility to Pneumocystis jirovecii and Cryptosporidium as opportunistic infections caused by the secondary T cell cooperation defect.

Can you avoid these mistakes?

A 9-month-old male presents with his third episode of bacterial otitis media. Labs show absent circulating B cells and very low IgG, IgA, and IgM. His maternal uncle had a similar history. What is the defective protein, and why didn't this child present in the first few months of life?
A 28-year-old woman with a history of recurrent respiratory infections requires a blood transfusion after surgery. Within minutes of starting the transfusion she develops hypotension, urticaria, and bronchospasm. Her labs show IgA level <7 mg/dL with normal IgG and IgM. What is the mechanism of her reaction, and what type of blood product should she have received?
A 6-year-old boy has recurrent bacterial pneumonias and a recent Pneumocystis jirovecii infection. Labs show markedly elevated IgM, undetectable IgG and IgA, and normal B cell count. What is the molecular defect, and why does this condition predispose to opportunistic infections not typically seen in pure B cell deficiencies?
You see two patients: Patient A is a 7-month-old male with absent B cells and pan-hypogammaglobulinemia; Patient B is a 32-year-old woman with normal B cell count, pan-hypogammaglobulinemia, and a recent diagnosis of autoimmune hemolytic anemia. Name the diagnosis for each patient and identify two clinical features that distinguish them beyond age and sex.

Related topics

B Cell Activation, Class Switching, Somatic Hypermutation Thymus and T Cell Maturation Spleen Architecture and Function Lymph Node and MALT Architecture Innate Immune Cells Overview

See how your Anki deck covers this topic.

Upload your deck for a free audit →